Shift Engineer - Respiratory GMP Manufacturing

Glaxosmithkline Consumer Healthcare SA; Ware; On-site; GBP 60,000 - 80,000; Full time

Job summary

A global biopharma company in Ware, England seeks a qualified engineer to support manufacturing operations in a complex GMP environment. This role involves managing people and equipment, driving performance improvements, and working with diverse stakeholders. Ideal candidates have engineering qualifications, experience in regulatory audits, and a continuous improvement mindset. Competitive salary and benefits offered, including professional development opportunities. Applications close on January 30, 2026.

Benefits

Competitive base Salary

Shift allowance

Annual bonus based on company performance

On-the-job training opportunities

Attendance at industry conferences

Support for professional development

Access to healthcare programmes

Employee recognition programmes

Qualifications

• Qualified engineer with experience in a GMP environment.
• Ability to develop process understanding across the site.
• Experience in dealing with regulatory audit questions.

Responsibilities

• Manage and develop People, Plant, and Equipment understanding.
• Support production activities alongside contractors and suppliers.
• Ensure delivery of the Site’s commercial strategy.

Skills

Strong experience in a complex GMP environment

Ability to drive performance

Strong people skills

Continuous improvement mindset

Ability to deal with diverse stakeholders

Education

Engineering HND/degree

Job description

A global biopharma company in Ware, England seeks a qualified engineer to support manufacturing operations in a complex GMP environment. This role involves managing people and equipment, driving performance improvements, and working with diverse stakeholders. Ideal candidates have engineering qualifications, experience in regulatory audits, and a continuous improvement mindset. Competitive salary and benefits offered, including professional development opportunities. Applications close on January 30, 2026.